Condition: Primary Biliary Cholangitis · Sponsor: Xijing Hospital of Digestive Diseases
The main objectives of the study were to assess the effects of fenofibrate on serum alkaline phosphatase, as a composite endpoint and on safety in participants with primary biliary cholangitis (PBC).
This description comes directly from the study's public registry record.
Yulong Shang · +86-29-84771539 · shangyl870222@163.com
Ying Han · +86-29-84771539 · hanying1@fmmu.edu.cn
Always discuss trial participation with your own doctor first.
| Peking Union Medical College Hospital | Beijing, Beijing Municipality, China | Recruiting |
| Sun Yat-sen Memorial Hospital | Guangzhou, Guangdong, China | Not Yet Recruiting |
| Henan Provincial People's Hospital | Zhengzhou, Henan, China | Recruiting |
| Xiangya Hospital Central South University | Changsha, Hunan, China | Recruiting |
| Jiangsu Province Hospital | Nanjing, Jiangsu, China | Recruiting |
| The First Hospital of China Medical University | Shenyang, Liaoning, China | Recruiting |
| Xijing Hospital | Xi'an, Shaanxi, China | Recruiting |
| Yan'an University Affiliated Hospital | Yan’an, Shaanxi, China | Recruiting |
| Sichuan Provincial People's Hospital | Chengdu, Sichuan, China | Recruiting |
| Tianjin Third Central Hospital | Tianjin, Tianjin Municipality, China | Recruiting |
| The Second Affiliated Hospital of Kunming Medical University | Kunming, Yunnan, China | Recruiting |
| Tianjin Medical University General Hospital | Tianjin, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05749822